This inventor holds 1 USPTO granted patent. Top assignee: Kyoto Pharmaceutical Industries, Ltd.. Active years: 2008.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2008
Title: Kenji Takahashi: Innovator in Medicinal Chemistry
Introduction
Kenji Takahashi is a prominent inventor based in Kyoto, Japan. He has made significant contributions to the field of medicinal chemistry, particularly through his innovative research and development of pharmaceutical compounds.
Latest Patents
Takahashi holds a patent for an indoline compound and its medicinal use. This invention provides an indoline compound represented by a specific formula, or a pharmaceutically acceptable salt thereof. The compound demonstrates superior ACAT inhibitory effects and superior lipoperoxidation inhibitory effects, making it useful as an ACAT inhibitor or a lipoperoxidation inhibitor.
Career Highlights
Kenji Takahashi is associated with Kyoto Pharmaceutical Industries, Ltd., where he has been instrumental in advancing pharmaceutical research. His work focuses on developing compounds that can significantly impact health and medicine.
Collaborations
Takahashi has collaborated with notable colleagues, including Shouji Kamiya and Miho Ikai. These partnerships have fostered a collaborative environment that enhances innovation and research outcomes.
Conclusion
Kenji Takahashi's contributions to medicinal chemistry through his patented indoline compound highlight his role as an influential inventor in the pharmaceutical industry. His work continues to pave the way for advancements in medical treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile